Klebsiella oxytoca strain HB60 is highly resistant to cefoperazone and aztreonam (MICs = 128 mg/L). It produces a chromosomally encoded -lactamase of pI 5.7 which was highly efficient against penicillins, first-generation cephalosporins and cefoperazone, a nonoxyimino third-generation cephalosporin. Aztreonam and oxyimino broad-spectrum cephalosporins were less good substrates. The -lactamase activity was susceptible to inhibition by clavulanic acid (IC 50 = 1 M). The enzyme purified to homogeneity had a specific activity towards benzylpenicillin of 3670 U/mg. The 263 amino acid residues of the protein were sequenced by Edman degradation of proteolytic peptides. The -lactamase was shown to belong to the OXY-2 group as it had only one amino acid substitution (Asn for Asp at ABL position 197) compared with the -lactamase (pI 5.2) from the aztreonam-susceptible K. oxytoca strain SL911 and two substitutions (Ala223 for Val and Asp255 for Asn) compared with the -lactamase (pI 6.4) from the aztreonam-resistant K. oxytoca strain D488. These three OXY-2-group enzymes behave in the same way towards -lactam antibiotics. The variability in the resistance of these K. oxytoca strains would thus seem to be due to variation in the level of production of the -lactamases rather than to structural alteration of the enzymes.
Introduction
Most bacteria resistant to -lactam antibiotics produce a serine active-site -lactamase. -Lactamases are classified, based on their structure, into three classes, A, C, and D. [1] [2] [3] From a clinical point of view, class A is the most important as it contains enzymes that confer resistance to penicillins and to first-and second-generation cephalosporins as well as to all the main broad-spectrum -lactam antibiotics such as third-generation cephalosporins, carbapenems and monobactams. 4 Together with Enterobacter spp. and Serratia spp., Klebsiella oxytoca is responsible for 30% of nosocomial infections. Generally, K. oxytoca spp. produce a class A -lactamase [5] [6] which hydrolyses penicillins, narrowspectrum cephalosporins and, to a lesser extent, third-generation cephalosporins such as cefoperazone and ceftriaxone, and the monobactam, aztreonam. 5, [7] [8] [9] [10] Usually, the resistance phenotype of the isolates is restricted to penicillins, e.g. amoxycillin and ticarcillin, as a result of a low level of biosynthesis of -lactamase. 8 Following the intensive use in the early 1980s of broadspectrum -lactam antibiotics in clinical practice, up to 10% of isolates became resistant to cefoperazone and aztreonam. 8, 11 This might be related to the observation that 8-10% of clinical isolates were found to hyperproduce the
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Characterization and amino acid sequence of the OXY-2 group -lactamase of pI 5.7 isolated from aztreonam-resistant Klebsiella oxytoca strain HB60 6 as the result of a point mutation in the consensus sequence of the promoter. 6 These isolates were still susceptible to oxyimino cephalosporins, although the MICs of cefotaxime and ceftriaxone were increased about 50-fold. 10, 11 Recently, a colony hybridization study of K. oxytoca strains of worldwide origin demonstrated that the chromosomally encoded -lactamase genes could be divided into two groups, bla oxy-1 and bla oxy-2 .
12 Within each group, four different variants could be distinguished based on pI values. One OXY-1 -lactamase of pI 7.5 5 and two OXY-2 -lactamases of pI 5.2 12 and pI 6.4 9 have been sequenced. In this paper we report the characterization and the amino acid sequence of the OXY-2 -lactamase of pI 5.7 purified from the clinical strain K. oxytoca HB60, isolated for its high resistance to aztreonam.
Materials and methods
Bacterial strain
K. oxytoca strain HB60 was isolated at Hôpital Begin (Pr. Thabaut, Saint-Mandé, France). It was identified using the API 20E system and Biotype 100-carbon source strips (bioMérieux SA, Marcy l'Etoile, France).
Susceptibility testing
MICs were determined by a two-fold microdilution method in Mueller-Hinton broth (Difco, Fisher Scientific-OSI, Elancourt, France). MICs were read after 18 h incubation of an inoculum of 5 10 5 cfu/mL at 37°C. The MIC of amoxycillin was measured alone or in combination with potassium clavulanate (2 mg/L).
Transfer of resistance phenotype and detection of plasmid DNA
The rifampicin-resistant Escherichia coli strain K-12 J53-2 was used as the receptor strain in conjugative transfer experiments. 13 Agar plates containing rifampicin (100 mg/L) and amoxycillin (8 mg/L) were used for transconjugant selection. Plasmid DNA content of HB60 strain was analysed by the procedure of Kado & Liu. 14 
Purification of the -lactamase
The methods used for bacterial cultures, cell disruption, ammonium sulphate fractionations, adsorption on to and elution from DE52 cellulose (Whatman, Maidstone, UK) and chromatography on Sephadex G-100 (Pharmacia Biotech, Orsay, France) were as described previously. 9, 15 Ion-exchange HPLC was carried out on a Mono Q HR 5/5 column (Pharmacia) equilibrated with 20 mM Tris-HCl buffer, pH 7.7. Samples (400 L) containing 5 mg (3290 U) of protein mixture from exclusion chromatography, in the same buffer, pH 7.7, were applied and the proteins eluted with a 500 mM NaCl, 20 mM Tris-HCl buffer, pH 7.7. Fractions with -lactamase activity (330 mM NaCl) were pooled and desalted by reversed phase HPLC through a 7 m Nucleosil C18 500 Å (4.6 250 mm) column (Interchim, Montlucon, France) eluted with acetonitrile in 0.1% (v/v) aqueous trifluoroacetic acid. After evaporation of the organic solvent, the -lactamase was freeze-dried. The purity of the preparation was checked by N-terminal sequence analyses.
Analytical isoelectrofocusing
The pI was determined by analytical isoelectrofocusing in sucrose density and ampholyte gradients (pH range from 4.5 to 8.5) with an LKB 8101 column.
-Lactamase assays
One unit of -lactamase activity is defined as the amount of enzyme hydrolysing 1 mol of benzylpenicillin at 37°C and pH 7. During the purification procedure and for the phydroxymercuribenzoate inhibition study, the enzymatic activity was detected spectrophotometrically at 235 nm in 50 mM sodium phosphate buffer, pH 7, with 800 M benzylpenicillin as substrate. For inhibition by p-hydroxymercuribenzoate, inhibitor (0.1 mM) and -lactamase (2 U) were incubated for 5 min before addition of the substrate. The -lactamase from K. oxytoca D488, 9 an enzyme of the OXY-2 group 12 , and the OXY-like MEN-1 -lactamase 16 were included in the inhibition study. The kinetic parameters, k cat and K m were determined using a microacidimetric method. 17 For the clavulanate inactivation study, the enzyme and inhibitor in different molar ratios were incubated for 10 min at 37°C. Then, the remaining activity against benzylpenicillin was measured. The data were plotted against inhibitor concentration to determine IC 50 , and against the inhibitor:enzyme ratio to determine the turnover number from the extrapolated value for 100% inactivation.
Trypsin and chymotrypsin proteolysis and carboxymethylation of peptides
Three milligrams (103 nmol) of -lactamase were suspended in 1.5 mL of 0.05 M Tris-HCl buffer, pH 8.3. The protein was digested with 20 g of trypsin (type XIII, Sigma, St Quentin Fallavier, France) or chymotrypsin (type VII, Sigma) for 2 h at 25°C. The peptide mixtures were carboxymethylated and then separated by reversed phase HPLC as described previously. 16, 18, 19 
-Lactamase digestion and subfractionation of tryptic peptides T-18a and T-20 by endoproteinase Asp-N
One hundred and three nmol of -lactamase, or 20 nmol of peptides, were dissolved in 400 L of 8 M urea for 30 min.
The protein, or peptides, were then digested for 6 h at 37°C by adding 6 g of endoproteinase Asp-N in 1.2 mL of 75 mM potassium phosphate buffer, pH 8. The resulting proteolytic peptides were subjected to reversed phase HPLC separations as previously reported.
18,19
Purification of proteolytic peptides
Proteolytic fragments were separated at pH 2 by reversed phase HPLC on a 5 m Nucleosil C 18 (4 250 mm) column (Interchim) eluted with a gradient of acetonitrile in 0.1% aqueous trifluoroacetic acid as described previously. 18 Tryptic, chymotryptic and endoproteinase Asp-N peptides were designated T, C and D, respectively. Peptides were numbered in the order in which they eluted from reversed phase HPLC at pH 2. Peptides recovered from subsequent chromatography at pH 6 were indicated by Roman numerals whereas lower case letters indicate peptides separated from a final chromatography under isocratic elution at pH 2.
Amino acid composition and sequence analyses
The methods for hydrolysis (1 nmol), amino acid composition analysis, 4-N,N-dimethylaminoazobenzene-4 -isothiocyanate/phenylisothiocyanate double coupling Edman degradation (2-10 nmol) of peptides, as well as the method for quantitative determination of N-terminal amino acid derivatives by HPLC, have been described previously. 16, 18 Amino acid sequence accession number
The amino acid sequence of the -lactamase from K. oxytoca strain HB60 has been submitted to the EMBL database and assigned the accession number P23954.
Results
Antibiotic susceptibility
The K. oxytoca strain HB60 was highly resistant to penicillins (MICs of amoxycillin, ticarcillin and piperacillin 1024 mg/L), narrow-spectrum cephalosporins (MIC of cephalothin 256 mg/L), aztreonam (MIC 128 mg/L) and susceptible to cefoxitin (MIC 2 mg/L), imipenen (MIC 0.12 mg/L) and third-generation cephalosporins (MICs of cefotaxime and ceftazidime 2 mg/L) with the exception of cefoperazone (MIC 128 mg/L). Clavulanic acid lowered the susceptibility to penicillins although the strain was still resistant to the combination of amoxycillin and clavulanate (MIC 16 mg/L).
Location of -lactamase determinant
No E. coli K12 J53-2 transconjugants were selected after overnight mixed incubation of K. oxytoca HB60 and the recipient strains. Moreover, analysis of DNA extracts from the K. oxytoca strain by electrophoresis in a 0.7% agarose gel did not reveal any plasmid DNA band. These results all suggested that the bla gene was encoded chromosomally rather than by a plasmid.
-Lactamase purification
The -lactamase was purified by a five-step procedure as summarized in Table I . The purified enzyme was adsorbed tightly on dialysis membrane. Therefore, the active fractions recovered from anion-exchange HPLC were desalted by reversed phase HPLC. The -lactamase was purified 400-fold from crude extract of 9 U/mg specific activity. Reversed phase analysis of the Edman derivative of the Nterminal amino acid indicated a protein purity of 96%. By analytical isoelectric focusing in a sucrose density gradient the pI was found to be 5.7.
Kinetic parameters
The substrate profile was determined with a partially purified protein (658 U/mg). The k cat values were calculated from activities determined with highly purified -lactamase and a molecular mass deduced from the amino acid sequence of the enzyme. The data for k cat , K m and catalytic efficiency (k cat /K m ) are shown in Table II . As expected from antibiotic susceptibilities, penicillins and narrowspectrum cephalosporins were the best substrates for the -lactamase of K. oxytoca HB60. With high K m values, methoxyimino third-generation cephalosporins were hydrolysed to a much lesser extent. For example, the catalytic efficiency for cefotaxime was only 1.5% of that for amoxycillin. Conversely, the catalytic efficiency for cefoperazone, a non-oxyimino third-generation cephalosporin, was identical to that for cephaloridine. That was the result of a low K m value since, of the substrates, cefoperazone presented the lowest k cat . The -lactamase hydrolysed aztreonam significantly with a k cat /K m value as high as that of broad-spectrum cephalosporins although the strain was 64-fold more susceptible to cefotaxime than to the monobactam. Cephamycins and imipenem were not affected by the enzyme. The -lactamase was inhibited by clavulanate with a IC 50 of 1 M. The inactivation was progressive with a turnover number of 560 and a K i of 0.12 M. A solution of 0.1 mM p-hydroxymercuribenzoic acid inhibited 93% of the -lactamase activity against benzylpenicillin. In the same conditions we found 97% inhibition of thelactamase from K. oxytoca D488 and 80% inhibition of the plasmid-mediated MEN-1 -lactamase.
Amino acid sequence determination
The strategy used to establish the sequence of the -lactamase from Edman degradation analyses of intact protein and proteolytic peptides is shown in the Figure. An initial reversed phase HPLC at pH 2 of the tryptic digest separated 22 peaks from which 29 peptides were recovered by additional chromatography at pH 2 or 6. After amino acid composition analysis, 19 peptides were subjected to Edman degradation. Except for T-18a and T-20, the complete amino acid sequences of the 19 tryptic peptides were determined (Figure) . In most cases, lysine residues were not identified as Edman derivatives but were deduced from amino acid composition analyses. Peptide T-2 was placed N-terminally by comparison with the sequence of the intact protein whereas T-8, which ended with a leucine residue, was located at the C-terminal. Three fragments, at positions 16-19, 37-40 and 247-249, were not recovered. The corresponding peptides eluted from the HPLC column with the buffer peak. The primary structure of the 36-residue long peptide T-20 was fully determined by analysis of peptide T-20 D-4 resulting from fractionation of the parent peptide by Asp-N endoproteinase. In the same way, Edman degradation of peptide T-18a D-4 extended the amino acid sequence determination of peptide T-18a up to residue 243, which corresponds to position 270 according to the standard numbering scheme for class A -lactamases (ABL). 20 The overlaps between tryptic peptides and the identification of the domains remaining unidentified were carried out by analyses of peptides obtained from chymotryptic and endoproteinase Asp-N digests as indicated in the Figure. The -lactamase of K. oxytoca HB60 consisted of 263 residues with a molecular mass of 28,287 Da.
Discussion
K. oxytoca exhibits a resistance phenotype which may be restricted to penicillins or extended to first-generation cephalosporins as well as to broad-spectrum -lactam antibiotics such as aztreonam and cefoperazone. 5, 8, 11 Whatever their susceptibilities to -lactam antibiotics K. oxytoca strains produce one of a set of chromosomally encoded -lactamases characterized by eight pI values and belonging to two structurally different groups, OXY-1 and OXY-2. 12 Two enzymes of the OXY-2 group have been sequenced. The amino acid sequence of -lactamase of pI 5.2, isolated from the aztreonam-susceptible (MIC 0.12 mg/L) strain SL911, [1] [2] [3] differed from that of the pI 6.4 -lactamase from an aztreonam-resistant (MIC 32 mg/L) strain D488 9 by only three amino acid substitutions: Asp for Asn at ABL 197, Ala for Val at ABL 223 and Asp for Asn at ABL 255. Recently, the amino acid sequence of the -lactamase RbiA produced by the aztreonam-resistant (MIC 128 mg/L) K. oxytoca strain SB23 has been reported. 10 It was claimed that the protein differed from that of strain D488 by three substitutions: Asp for Asn at ABL-191, Ala for Val at ABL-223 and Asp for Asn at Twenty micrograms of -lactamase gave no dedectable hydrolysis ( 0.01 mol/min). The K m was determined as K i by substrate competition with benzylpenicillin.
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ABL-254. Actually, the ABL numbering scheme was partially misinterpreted and the three substitutions occurred at positions 197, 223 and 255, respectively. Finally, the sequences of the -lactamase from strain SL911 and the RbiA enzyme are identical. The aztreonam-resistant K. oxytoca HB60 strain produced a -lactamase that has been purified to protein homogeneity. For the last step of the purification procedure, fractions with -lactamase activity were desalted by reversed phase HPLC, as the purified enzyme adsorbed on to dialysis membrane. The same feature has previously been observed during the purification of the -lactamase from K. oxytoca D488 9 and the OXY-like MEN-1 enzyme. The amino acid sequence of the -lactamase from K. oxytoca HB60 exhibits one substitution (Asn for Asp at ABL 197) compared with the OXY-2 group protein (pI 5.2) from strains SL911 12 or SB23, 10 and two substitutions (Ala for Val at ABL 223 and Asp for Asn at ABL 255) compared with the protein (pI 6.4) from strain D488 9 (see Figure) . Therefore, the protein of pI 5.7 of K. oxytoca HB60 is one of the four enzymes which constitute the OXY-2 group of -lactamases. 12 As has been suggested, the proteins of this group differ by only a few amino acid substitutions, 12 whereas there are 24 amino acid substitutions between the sequence of OXY-1 -lactamase from strain E23004 5 and that of OXY-2 -lactamase from strain HB60.
Kinetic constant values of the -lactamase of K. oxytoca HB60 (Table II) were rather similar to those reported for other chromosomal enzymes recovered from K. oxytoca. 5, [7] [8] [9] [10] 21 Penicillins and narrow-spectrum cephalosporins were highly hydrolysed, while aztreonam and methoxyimino third-generation cephalosporins were less good substrates but were hydrolyzed significantly. Of the broad-spectrum cephalosporins, cefoperazone was the best substrate. 5, 8 Clavulanate inhibited -lactam hydrolysis with IC 50 and K i values similar to those encountered within class A -lactamases susceptible to this inhibitor. 4, 22, 23 The -lactamase was as strongly inhibited by p-hydroxymercuribenzoate as was the OXY-2 group -lactamase from strain D488 or the MEN-1 enzyme. Owing to the presence of a cysteine residue at position 69, close to the activesite serine, that behaviour was expected although it has been claimed that the inhibitor does not alter the activity of the enzyme from K. oxytoca E23004 strain. 5 In terms of catalytic efficiencies, the three sequencedlactamases of the OXY-2 group were kinetically identical (Table III) . The enzymes of that group belong to Ambler's class A. The catalytic cavity of these enzymes is mainly made of nine residues at positions Ser70, Lys73, Ser130, Asn132, Glu166, Asn170, Lys(Arg)234, Thr(Ser)235 and Ala237 (ABL numbering). A dense hydrogen bond network is established between these residues, two water molecules and the substrate; this correctly positions the carboxyl moiety of the -lactam ring which acylates the active site serine at position 70. 24 All amino acid substitutions known to alter the catalytic activity of class Alactamases are in the vicinity of the residues making up the catalytic cavity. 25 Positions 197, 223 and 255, where the amino acid substitutions within the sequences of the OXY-2 group proteins occur, are apparently too distant from the reactive pocket to interact in the catalytic mechanism. Moreover, K. oxytoca strains SB23 10 and SL911 12 differ in their susceptibility to third-generation cephalosporins and aztreonam though they both produce the samelactamase. Therefore, the great diversity of K. oxytoca susceptibilities towards -lactam antibiotics cannot be explained by structural features of the biosynthesizedlactamases. However, it has been demonstrated that the aztreonam-resistance phenotype of K. oxytoca E23004, 5 
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10 and SL7811 26 co-transferred with a plasmid in which the -lactamase-encoding genes were cloned. Thus the production of -lactamase is predominantly responsible for the resistance of these strains. The high level of resistance of K. oxytoca to aztreonam and cefoperazone has been shown to be related to overproduction of the OXY-group enzymes. 6, 11 The overproduction is the result of a single mutation in either the 10 or 35 conserved sequences of the promoter. 6 Thus, the 145-fold increase in the biosynthesis of the OXY-2 group -lactamase of pI 5.2 by K. oxytoca SB23 10 is the result of the mutation A for G at the fifth position of the -10 sequence of the promoter of K. oxytoca SL911. 12 It follows that the MICs of aztreonam and cefotaxime for strain SB23 are 1000 times higher than those for strain SL911. The specific activity of crude extract from K. oxytoca HB60, 9 units per mg of total protein, is quite similar to those of K. oxytoca strains overproducing the chromosomal -lactamase. 6 Thus, the resistance of strain HB60 towards cefoperazone and aztreonam would seem to be related to a high level of transcription of the -lactamase gene.
With the exception of a point mutation in the Pribnow box and an extra codon CGC in the peptide leader-encoding DNA the 989 bp sequence spanning the -lactamase gene of strain SL911, from France, 12 and that of strain SB23, from Japan, 10 are identical. Moreover bla oxy probes hybridize with numerous K. oxytoca strains recovered in Europe or the USA. 12 We can expect that the bla oxy gene will be incorporated into a transposable element and that the cefoperazone-and aztreonam-resistant phenotype will then be disseminated to other Gram-negative species. 
